“Some Aggressive Cancers May Respond to Anti-inflammatory Drugs,” Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Studying triple-negative breast cancer, researchers at the Siteman Cancer Center and Washington University School of Medicine found that some aggressive tumors rely on an antiviral pathway that appears to drive inflammation, widely recognized for roles in cancer, rheumatoid arthritis and other inflammatory diseases. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine is one of the 25 NCCN Member Institutions. ...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news